| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NUVB over the last quarter tilts toward selling: insiders offloaded a net 100,000 shares worth roughly $709K.
Classified under Biotechnology (Health Care sector), NUVB's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 225.0K | $1.06M | - | |
| Other | 68.1K | - | - | |
| CFO | 54.1K | $106.6K | - | |
| Other | 53.0K | $319.0K | - | |
| Other | 32.6K | $60.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Hattersley Gary | Chief Scientific Officer | Sale+OE | 100,000 | $7.09 | $709,240.00 | - | - | - | |
| Jun 23, 2026 | Markel Stacy | Chief People Officer | Sale+OE | 125,000 | $6.03 | $753,187.50 | -79.3% | +0.5% | - | |
| Jun 23, 2026 | Wentworth Kerry | Chief Regulatory Officer | Sale+OE | 63,000 | $6.02 | $379,190.70 | -54.3% | +0.5% | - | |
| Jun 23, 2026 | Sauvage Philippe | Chief Financial Officer | Sale+OE | 47,668 | $6.01 | $286,370.28 | -79.0% | +0.5% | - | |
| Jun 9, 2026 | Mashal Robert | Director | Buy | 25,000 | $4.73 | $118,250.00 | +12.5% | +34.1% | - | |
| Apr 17, 2026 | Liu Dongfang62 | Chief Medical Officer | Sale+OE | 50,000 | $5.02 | $251,000.00 | -73.5% | +11.0% | - | |
| Apr 17, 2026 | Wentworth Kerry | Chief Regulatory Officer | Sale+OE | 36,750 | $5.01 | $184,279.20 | -40.9% | +11.0% | - | |
| Apr 6, 2026 | Wentworth Kerry | Chief Regulatory Officer | Sale+OE | 200,000 | $4.52 | $903,560.00 | -79.1% | +25.8% | - | |
| Dec 1, 2025 | Liu Dongfang62 | Chief Medical Officer | Sale+OE | 150,000 | $7.82 | $1,173,255.00 | -89.3% | -25.9% | - | |
| Nov 26, 2025 | Liu Dongfang62 | Chief Medical Officer | Sale+OE | 20,000 | $7.75 | $155,000.00 | -52.6% | -29.6% | - |